# A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment

> **NCT06562114** · PHASE1 · COMPLETED · sponsor: **Merry Life Biomedical Co., Ltd.** · enrollment: 72 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TML-6 Granules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06562114
- **Lead sponsor:** Merry Life Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-11
- **Primary completion:** 2025-07-18
- **Final completion:** 2025-08-15
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06562114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06562114, "A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06562114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*